Is the price fair?
What LFST's price assumes
LifeStance Health Group, Inc. trades at 93.5× earnings against 19.7× for the median Medical Care Facilities name, more expensive than its own group.
93.5
Trailing P/E · Medical Care Facilities median 19.7 · 4.75× the median: the market pays up for this one
- Price / sales
- 1.68
Price / sales · as of 2026-Q1
- Free cash flow yield
- 5.1%
Free cash flow yield · Medical Care Facilities median 7.8%
- Growth the price implies
- +5.5%
Growth the price implies · The price pays for +5.5% free cash flow growth a year for a decade; revenue has grown +18% a year over the last three.
Details›
- Price / book2026-Q1
- 1.70
- EV / EBIT2026-Q1
- 58.1
- EV / sales2026-Q1
- 1.74
- Healthcare median P/E362 names
- 31.5
- Medical Care Facilities median P/E29 names
- 19.7
- Free cash flow, trailing twelve months
- $174M
- Market capitalisation
- $3.43B
- 3-year revenue growth
- +18%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Care Facilities
Ranks #13 of 28 by Smart Score